Related Experiment Video
Updated: Aug 12, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
An enzymatic defect in the obese (ob/ob) mouse: loss of thyroid-induced sodium- and potassium-dependent
Abstract:
Genetically obese (ob/ob) mice, mice that became obese after treatment with gold thioglucose, and lean animals were studied in the euthyroid state, after induction of hypothyroidism, and after treatment with triiodothyronine. The activity of glycerol 3-phosphate dehydrogenase (sn-glycerol-3-phosphate:(acceptor) oxidoreductase; EC 1.1.99.5] was reduced in the livers from hypothyroid animals and was increased by treatment with triiodothyronine in all groups. The activity of the ouabain-suppressible sodium- and potassium-dependent ATPase (ATP phosphohydrolase; EC 3.6.1.3) was increased by triiodothyronine and reduced by hypothyroidism in the lean and gold thioglucose-treated obese animals. In the obese (ob/ob) mice, on the other hand, treatment with triiodothyronine did not increase the activity of this enzyme, which remained at the level found in hypothyroid animals. This enzymatic activity was reduced in both liver and kidney. Adenylate cyclase [ATP pyrophosphate-lyase (cyclizing); EC 4.6.1.1] activity in liver membranes, however, was similar in all three groups of mice. This enzyme complex was activated by glucagon and was unaffected by treatment with thyroid hormones. The lack of a thyroid-dependent ouabain-suppressible (Na(+) + K(+))-ATPase in the tissues of the obese (ob/ob) mouse could explain most, if not all, of the abnormalities that have been described in this animal.
Insights
Thyroid hormones impact key enzymes in obese mice differently. Specifically, the obese (ob/ob) mouse lacks a thyroid-dependent sodium- and potassium-dependent ATPase, explaining its metabolic abnormalities.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Biochemistry
Background:
- Obesity is associated with altered metabolic pathways and hormonal regulation.
- Thyroid hormones play a crucial role in regulating energy metabolism and enzyme activity.
- Understanding enzymatic differences in obesity models is key to identifying therapeutic targets.
Purpose of the Study:
- To investigate the impact of thyroid status on key metabolic enzymes in different models of obesity.
- To elucidate the role of specific enzymes, such as glycerol 3-phosphate dehydrogenase and (Na⁺ + K⁺)-ATPase, in the pathogenesis of obesity.
- To determine if abnormalities in thyroid hormone-responsive enzymes contribute to the metabolic phenotype of genetically obese (ob/ob) mice.
Main Methods:
- Comparative analysis of enzyme activities in liver and kidney tissues from lean, gold thioglucose-induced obese, and genetically obese (ob/ob) mice.
- Experimental manipulation of thyroid status: euthyroid, induced hypothyroidism, and triiodothyronine treatment.
- Assay of glycerol 3-phosphate dehydrogenase, ouabain-suppressible sodium- and potassium-dependent ATPase, and adenylate cyclase activities.
Main Results:
- Glycerol 3-phosphate dehydrogenase activity was reduced in hypothyroidism and increased with triiodothyronine in all groups.
- Lean and gold thioglucose-obese mice showed increased (Na⁺ + K⁺)-ATPase activity with triiodothyronine and decreased activity with hypothyroidism.
- Obese (ob/ob) mice exhibited a lack of thyroid hormone-dependent increase in (Na⁺ + K⁺)-ATPase activity, which remained low.
Conclusions:
- The impaired response of (Na⁺ + K⁺)-ATPase to thyroid hormones in obese (ob/ob) mice is a significant finding.
- This enzymatic deficit in obese (ob/ob) mice may underlie their characteristic metabolic abnormalities.
- Adenylate cyclase activity was similar across groups and unaffected by thyroid hormones, suggesting a specific role for ATPase dysfunction.
Related Concept Videos
ATP Synthase: Mechanism
ATP Synthase: Structure
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Inborn Errors of Metabolism
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

